YOLFTbeta
68

HOB Biotech Group Corp Ltd

688656 · SHG · Healthcare / Medical Devices

99.00CNY-4.35 (-4.21%)

Price History

Full chart

Market Stats

Previous Close103.35
Open103.32
Day Range98.50 – 104.43
52-Week Range76.62 – 216.61
Volume428.77K
Market Cap8.37B
P/E (TTM)292.71
Forward P/E0.00
EPS0.45
Dividend Yield0.15%
Beta-0.28
50-Day Avg104.60
200-Day Avg123.23

About

HOB Biotech Group Corp.,Ltd. operates as an in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immune assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. HOB Biotech Group Corp.,Ltd was founded in 2009 and is based in Suzhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. John Li
  • Employees525
  • HeadquartersNo. 9, Dongyanli Road, Suzhou, China, 215009, China
  • Websitehttps://www.hobiotech.com

Leadership

  • Mr. John LiChairman & GM · b. 1963
  • Mr. Zhang YangqingCFO & Director · b. 1968
  • Ms. Aixiang XieSecretary & Director · b. 1982
  • Chun Li LiAccounting Supervisor

Financials

Income Statement

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue111.60M146.32M201.45M259.13M221.86M317.71M320.39M394.41M402.34M398.40M
Growth (%)-+31.11%+37.68%+28.63%-14.38%+43.20%+0.84%+23.10%+2.01%-0.98%
Cost of Revenue38.34M44.31M59.16M82.73M76.40M98.55M118.14M149.41M145.16M165.62M
Gross Profit73.26M102.01M142.29M176.39M145.46M219.16M202.26M244.99M257.18M232.78M
Gross Margin65.64%69.72%70.63%68.07%65.56%68.98%63.13%62.12%63.92%58.43%
Operating Expense70.11M77.43M93.13M106.34M80.36M121.64M154.69M189.15M215.80M205.95M
Operating Income3.15M24.59M49.16M70.05M65.10M97.52M47.57M55.84M41.38M26.83M
Operating Margin2.82%16.80%24.41%27.03%29.34%30.70%14.85%14.16%10.29%6.73%
EBITDA7.41M34.00M57.85M88.25M82.39M120.10M75.50M92.55M83.22M63.80M
EBITDA Margin6.64%23.23%28.72%34.06%37.14%37.80%23.57%23.47%20.68%16.01%
Net Income4.34M21.35M40.15M63.84M56.62M86.19M41.65M47.33M36.80M23.20M
Net Income Margin3.88%14.59%19.93%24.64%25.52%27.13%13.00%12.00%9.15%5.82%
R&D23.35M19.69M24.15M25.44M24.13M31.79M38.74M47.01M46.27M47.76M
R&D as % of Total Revenue20.92%13.45%11.99%9.82%10.88%10.00%12.09%11.92%11.50%11.99%
Interest Expense1.59M1.97M1.71M1.38M1.89M1.24M2.09M2.81M3.04M2.42M
Interest Expense % of Total Revenue1.42%1.35%0.85%0.53%0.85%0.39%0.65%0.71%0.76%0.61%

Balance Sheet

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets124.65M144.22M225.22M283.18M296.41M863.92M944.56M949.26M1.03B931.30M
Total Liabilities67.94M65.20M92.10M133.54M90.02M93.92M164.99M138.52M220.67M111.30M
Total Equity56.71M79.03M133.12M149.64M206.39M770.00M779.57M810.73M812.14M820.01M
Cash13.00M14.02M66.52M90.76M58.82M449.86M153.80M163.47M121.63M63.34M
Total Debt37.54M36.98M19.03M50.07M44.00M30.88M65.43M51.06M114.59M46.16M
Net Debt24.54M22.96M-47.50M-40.69M-14.81M-418.98M-88.37M-112.41M-7.03M-17.18M

Cash Flow

Currency: CNY2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow6.42M22.26M46.51M68.57M58.22M104.79M58.31M102.69M101.22M72.94M
Investing Cash Flow-34.16M-18.11M-25.39M-33.75M-35.03M-154.39M-343.86M-39.55M-153.76M-50.42M
Financing Cash Flow26.45M-3.39M31.36M-10.55M-55.25M441.05M-10.85M-53.12M10.76M-85.90M
Capital Expenditure17.15M20.82M26.66M34.80M57.01M167.89M220.21M178.03M155.37M73.90M
Free Cash Flow-10.73M1.44M19.85M33.78M1.21M-63.09M-161.90M-75.34M-54.15M-961.33K
Dividends Paid1.53M1.84M1.66M47.29M49.19M18.92M33.42M20.79M28.17M20.79M
FCF to OCF-167.16%6.46%42.68%49.25%2.08%-60.21%-277.67%-73.36%-53.49%-1.32%
Dividend Paid to FCF-14.23%127.92%8.34%140.02%4056.71%-29.98%-20.64%-27.60%-52.03%-2162.76%

Earnings

Report DateApr 21, 2021Aug 18, 2021Oct 20, 2021Feb 25, 2022Apr 26, 2022Aug 24, 2022Oct 30, 2022Dec 31, 2022Apr 27, 2023
EPS Estimate---------
EPS Actual0.210.510.510.180.220.180.31-0.04-0.05
Surprise---------
TimingPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hours-Pre-market

Key Statistics & Ratios

Market Cap8.37B
Enterprise Value8.93B
Trailing P/E292.71
Forward P/E0.00
Price / Sales20.68
Price / Book10.78
EPS0.45
Book Value13.25
Revenue (TTM)404.51M
Gross Profit (TTM)238.66M
EBITDA83.72M
Profit Margin6.85%
Operating Margin14.31%
Return on Equity3.37%
Return on Assets1.47%
Shares Outstanding63.52M
Shares Float33.76M
Beta-0.28
Dividend Yield0.15%
Dividend Rate0.20
Payout Ratio44.44%

Dividends

20261×
0.20May 29, 2026
20251×
0.30May 29, 2025
20241×
0.40Jun 14, 2024
20231×
0.30Jun 13, 2023
20221×
0.53Jun 9, 2022
20211×
0.30Jun 10, 2021